Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-01
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 5, 2026
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriflunomid, ATC L04AK02 für die Zeit 01.10.2025 - 31.12.2025 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ginkgo-biloba-Blätter-Trockenextrakt, (OBG) ATC N06DP01 für die Zeit 01.01.2025 - 31.12.2026
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-01
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 5, 2026
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Baumpollen (ausschl. in der Dafo. Pumplösung), ATC V01AA05 f. d. Z. 01.01.25 - 31.12.26
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dexamethason (ausgenommen Implantat), (OBG) ATC S01BA01 für die Zeit 01.01.2025 - 31.12.2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Rotigotin, (OBG) ATC N04BC09 für die Zeit 01.01.2025 - 31.12.2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Apremilast, (OBO) ATC L04AA32 für die Zeit 01.01.2025 - 31.12.2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clindamycin + Benzoylperoxid, (OBG) ATC D10AF54 für die Zeit 01.01.2025 - 31.12.2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pyridostigmin (ausgenommen retardierte Dafo.), (OBG) ATC N07AA02 für die Zeit 01.01.2025 - 31.12.2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Sevelamer hydrochlorid, (OBG) ATC V03AE02 für die Zeit 01.01.2025 - 31.12.2026
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
grants.gov
The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-gene...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 5, 2026
The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, modeling, and validation with available large-scale datasets.
TEN
Poland – Electric buses – Zakup nowych zeroemisyjnych, elektrycznych autobusów do obsługi komunikacji publicznej
ted.europa.eu
Buyer: Przedsiębiorstwo Wielobranżowe Transkom Sp. z o.o. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-06
TenderProcurement ContractPolandOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 6, 2026
Buyer: Przedsiębiorstwo Wielobranżowe Transkom Sp. z o.o. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-06
GRA
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
grants.gov
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission...
GrantCash GrantUnited StatesOpen
AmountAward ceiling: $350,000
DeadlineNov 6, 2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific q...
GRA
DoW Parkinson’s, Investigator-Initiated Research Award
grants.gov
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidi...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 6, 2026
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research. Research must address at least one of the four FY26 PRP Focus Areas.Distinctive Features:· Partnering Principal Investigator (PI) Option: Allows for more than one PI. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI(s) will be identified as Partnering PI(s), with a maximum of two Partnering PIs.· Preliminary data are required.· Clinical trials are allowed.
GRA
DoW Parkinson’s, Early Investigator Research Award
grants.gov
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinson’s disease (PD) res...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 6, 2026
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinson’s disease (PD) research for investigators in the early stages of their careers. The FY26 EIRA offers two funding levels, which align to the research career stage of the Principal Investigator (PI). Funding Level 1 (for fellows) requires the investigator to receive guidance from a designated Mentor, whereas Funding Level 2 (for early-career independent investigators) does not. Proposed research must address at least one of the four FY26 PRP Focus Areas.Distinctive Features:· The Early Investigator is considered the PI of the application and must exhibit strong potential for and commitment to pursuing a career as an investigator at the forefront of PD research; however, the PI is not required to have previous PD research experience.· Funding Level 1: Applications must include at least one Mentor appropriate to the proposed research project who...
TEN
Spain – Hazard protection and control consultancy services – Sistema dinámico de adquisición de servicios de prevención de riesgos laborales ajenos.
ted.europa.eu
Buyer: Generalitat de Catalunya, Departamento de Economía y Finanzas, Comisión Central de Suministros | Notice type: cn-standard | Procedure: restrict...
TenderProcurement ContractSpainOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 7, 2026
Buyer: Generalitat de Catalunya, Departamento de Economía y Finanzas, Comisión Central de Suministros | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-11-07
TEN
France – Consultative engineering and construction services – Elaboration du schéma directeur patrimonial (SDP) de l'EPSVE dans le cadre de la reconversion du site de Neuilly sur Marne.
ted.europa.eu
Buyer: EPS de Ville Evrard | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-11-07
TenderProcurement ContractFranceOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 7, 2026
Buyer: EPS de Ville Evrard | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-11-07
TEN
Lithuania – Transformers – (2022-DPS-2) 40-630 kVA 10/0,4 kV įtampos trifaziai alyviniai galios transformatoriai
ted.europa.eu
Buyer: UAB „Ignitis grupės paslaugų centras“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-07
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 7, 2026
Buyer: UAB „Ignitis grupės paslaugų centras“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-07
TEN
Greece – Research and development services and related consultancy services – Establishment of a List of Individual External Experts to Assist ENISA
ted.europa.eu
Buyer: European Union Agency for Cybersecurity (ENISA) | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-11-08
TenderProcurement ContractGreeceOpen
AmountNot provided on the source page. Please check the official source.
DeadlineNov 8, 2026
Buyer: European Union Agency for Cybersecurity (ENISA) | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-11-08
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
40101
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-VerfahrenBuyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-05
40108
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Baumpollen (ausschl. in der Dafo. Pumplösung), ATC V01AA05 f. d. Z. 01.01.25 - 31.12.26Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, modeling, and validation with available large-scale datasets.
40118
Poland – Electric buses – Zakup nowych zeroemisyjnych, elektrycznych autobusów do obsługi komunikacji publicznejBuyer: Przedsiębiorstwo Wielobranżowe Transkom Sp. z o.o. | Notice type: cn-standard | Procedure: open | Contract: supplies | Dead...
Tender
Procurement Contract
Poland
Not provided on the source page. Please check the official source.
Buyer: Przedsiębiorstwo Wielobranżowe Transkom Sp. z o.o. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-06
40119
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes e...
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.
40120
DoW Parkinson’s, Investigator-Initiated Research AwardSummary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports high...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research. Research must address at least one of the four FY26 PRP Focus Areas.Distinctive Features:· Partnering Principal Investigator (PI) Option: Allows for more than one PI. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI(s) will be identified as Partnering PI(s), with a maximum of two Partnering PIs.· Preliminary data are required.· Clinical trials are allowed.
40121
DoW Parkinson’s, Early Investigator Research AwardSummary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinso...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinson’s disease (PD) research for investigators in the early stages of their careers. The FY26 EIRA offers two funding levels, which align to the research career stage of the Principal Investigator (PI). Funding Level 1 (for fellows) requires the investigator to receive guidance from a designated Mentor, whereas Funding Level 2 (for early-career independent investigators) does not. Proposed research must address at least one of the four FY26 PRP Focus Areas.Distinctive Features:· The Early Investigator is considered the PI of the application and must exhibit strong potential for and commitment to pursuing a career as an investigator at the forefront of PD research; however, the PI is not required to have previous PD research experience.· Funding Level 1: Applications must include at least one Mentor appropriate to the proposed research project who has experience in PD research and mentoring, as demonstrated by a record of active funding, recent publications, and successful mentorship. The selected Mentor(s) should also demonstrate a clear commitment to the development of the PI toward independence as a PD researcher. Preliminary data are encouraged but not required.· Funding Level 2: Mentor not required. Preliminary data are required.· Clinical trials are not allowed.
40122
Spain – Hazard protection and control consultancy services – Sistema dinámico de adquisición de servicios de prevención de riesgos laborales ajenos.Buyer: Generalitat de Catalunya, Departamento de Economía y Finanzas, Comisión Central de Suministros | Notice type: cn-standard |...
Tender
Procurement Contract
Spain
Not provided on the source page. Please check the official source.
Buyer: Generalitat de Catalunya, Departamento de Economía y Finanzas, Comisión Central de Suministros | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-11-07
40123
France – Consultative engineering and construction services – Elaboration du schéma directeur patrimonial (SDP) de l'EPSVE dans le cadre de la reconversion du site de Neuilly sur Marne.Buyer: EPS de Ville Evrard | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-11-07
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Buyer: UAB „Ignitis grupės paslaugų centras“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-11-07
40125
Greece – Research and development services and related consultancy services – Establishment of a List of Individual External Experts to Assist ENISABuyer: European Union Agency for Cybersecurity (ENISA) | Notice type: cn-standard | Procedure: restricted | Contract: services | D...
Tender
Procurement Contract
Greece
Not provided on the source page. Please check the official source.
